NCT03027778

Brief Summary

The purpose of this pilot study is to evaluate 1) the effect of intradialytic pedaling exercise on arterial stiffness and other arterial hemodynamic parameters over 4 months, and 2) the longer-term effect of pedaling on arterial stiffness and other arterial hemodynamic parameters 4 months after finishing the exercise intervention (8 months after study initiation). The investigators also aim to examine the impact of intradialytic pedaling exercise on general health, anthropometric measures, physical function, and routine laboratory blood markers as secondary outcome measures, as well as to assess feasibility, safety and adverse events associated with the intradialytic pedalling exercise. Recruitment of more participants in the future will be considered if warranted.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2015

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

January 17, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 23, 2017

Completed
Last Updated

March 21, 2018

Status Verified

March 1, 2018

Enrollment Period

9 months

First QC Date

January 17, 2017

Last Update Submit

March 20, 2018

Conditions

Keywords

arterial stiffnesshemodialysisintradialytic pedalling exercisecarotid-femoral pulse wave velocitychronic kidney diseasehemodynamicsaugmentation index

Outcome Measures

Primary Outcomes (1)

  • Change in non-invasive measures of arterial stiffness using applanation tonometry.

    4 months and 8 months after study initiation

Secondary Outcomes (3)

  • Change in gait speed using a 6 meter walk course and timer.

    4 months and 8 months after study initiation

  • Change in grip strength using a hand dynamometer.

    4 months and 8 months after study initiation

  • Safety and adverse events.

    8 months

Other Outcomes (12)

  • Change in peripheral and central blood pressure using a oscillometric cuff-based approach.

    4 months and 8 months after study initiation

  • Change in total cholesterol levels

    4 months and 8 months after study initiation

  • Change in triglyceride levels

    4 months and 8 months after study initiation

  • +9 more other outcomes

Study Arms (2)

Exercise

EXPERIMENTAL

Participants will engage in pedalling exercise 3 times per week during the first 2 hours of dialysis treatment for the duration of 4 months.

Other: Exercise

Usual care

NO INTERVENTION

Participants receive their usual dialysis for the duration of 4 months.

Interventions

Intradialytic pedalling exercise during regular dialysis sessions (3x per week) for 4 months

Exercise

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults with end-stage renal disease (stage 5 CKD), who were on a stable in-center hemodialysis regimen (approximately 4 hours 3 times per week) for ≥ 12 weeks prior to recruitment
  • A cardiac evaluation was required within the last year to ensure adequate cardiac function

You may not qualify if:

  • Any physical or psychological disability that would impact study participation, such as severe cerebrovascular disease (e.g., hemiparesis, cerebellar ataxia, etc.) or dementia
  • Serum intact parathyroid hormone(iPTH)\>250 pmol/L within 30 days prior to screening visit
  • Dysrhythmia or severe cardiac disease, such as congestive heart failure (CHF) Class III-IV, or unstable cardiovascular disease within 90 days prior to recruitment
  • Severe peripheral arterial disease
  • Severe hyperkalemia (\>6.5 milliequivalent/L) consistently the last 2 weeks
  • Current active cancer (excluding basal cell carcinoma of the skin)
  • Poorly controlled hypertension (post-dialytic systolic blood pressure ≥ 160mmHg or diastolic blood pressure≥ 100 mmHg) within 4 weeks prior to recruitment
  • Anticipated living donor kidney transplant or any other planned major surgery over the study duration
  • History of poor treatment adherence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Bernier-Jean A, Beruni NA, Bondonno NP, Williams G, Teixeira-Pinto A, Craig JC, Wong G. Exercise training for adults undergoing maintenance dialysis. Cochrane Database Syst Rev. 2022 Jan 12;1(1):CD014653. doi: 10.1002/14651858.CD014653.

  • Cooke AB, Ta V, Iqbal S, Gomez YH, Mavrakanas T, Barre P, Vasilevsky M, Rahme E, Daskalopoulou SS. The Impact of Intradialytic Pedaling Exercise on Arterial Stiffness: A Pilot Randomized Controlled Trial in a Hemodialysis Population. Am J Hypertens. 2018 Mar 10;31(4):458-466. doi: 10.1093/ajh/hpx191.

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Interventions

Exercise

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Stella S Daskalopoulou, MD, PhD

    McGill University Health Centre/Research Institute of the McGill University Health Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor in Medicine

Study Record Dates

First Submitted

January 17, 2017

First Posted

January 23, 2017

Study Start

February 1, 2015

Primary Completion

November 1, 2015

Study Completion

January 1, 2017

Last Updated

March 21, 2018

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share